Brief: Evoke Pharma And EVERSANA Extend Commercialization Partnership To Further Support GIMOTI
02/02/2022 13:59
Feb 2 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA AND EVERSANA EXTEND COMMERCIALIZATION
PARTNERSHIP
TO FURTHER SUPPORT GIMOTI
* EVOKE PHARMA INC - EXTENSION OF COLLABORATION WITH
EVERSANA ON
COMMERCIALIZATION AND DISTRIBUTION OF GIMOT NASAL SPRAY IN U.S.
THROUGH END OF 2026
Source text for Eikon: ID:nGNX73Kv4S
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary